When changes in the frequency of B cell subsets were evaluated by treatment, it was observed that the reduction in the number of CD19+CD24hiCD38hi B cells in active RA patients is not conditioned by differential treatment regime (14). Here, CD19 is linked to rheumatoid arthritis.